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OBJECTIVES Our objective was to prospectively examine the relation between vitamin C intake and risk of
coronary heart disease (CHD) in women.
BACKGROUND Results from prospective investigations of the relation between vitamin C intake and risk of
CHD have been inconsistent. The lack of clear evidence for a protective association despite
a plausible mechanism indicates the need to evaluate further the association between vitamin
C intake and risk of CHD.
METHODS In 1980, 85,118 female nurses completed a detailed semiquantitative food-frequency
questionnaire that assessed their consumption of vitamin C and other nutrients. Nurses were
followed up for 16 years for the development of incident CHD (nonfatal myocardial
infarction and fatal CHD).
RESULTS During 16 years of follow-up (1,240,566 person-years), we identified 1,356 incident cases of
CHD. After adjustment for age, smoking, and a variety of other coronary risk factors, we
observed a modest significant inverse association between total intake of vitamin C and risk
of CHD (relative risk [RR]  0.73; 95% confidence interval [CI] 0.57 to 0.94). Among
women who did not use vitamin C supplements or multivitamins, the association between
intake of vitamin C from diet alone and incidence of CHD was weak and not significant (RR
 0.86; 95% CI 0.59 to 1.26). In multivariate models adjusting for age, smoking, and a variety
of other coronary risk factors, vitamin C supplement use was associated with a significantly
lower risk of CHD (RR  0.72; 95% CI 0.61 to 0.86).
CONCLUSIONS Users of vitamin C supplements appear to be at lower risk for CHD. (J Am Coll Cardiol
2003;42:246–52) © 2003 by the American College of Cardiology Foundation
Vitamin C is the main water-soluble antioxidant in human
plasma (1) and is hypothesized to have a protective role in
the development of atherosclerotic heart disease (2) by
inhibiting low-density lipoprotein oxidation (3,4). Oxidized
low-density lipoprotein has been identified in atheroscle-
rotic lesions (5,6) and may be atherogenic in the vessel wall
through several mechanisms (7). In vitro, some studies have
demonstrated a significant reduction in the oxidizability of
low-density lipoprotein taken from the plasma of humans
supplemented with vitamin C alone or in combination with
vitamin E or beta-carotene (8–10).
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Several prospective studies have examined the relation
between vitamin C intake or vitamin C supplement use and
risk of coronary heart disease (CHD) (11). Higher dietary
intake of vitamin C has been associated with a moderately
lower risk of CHD among some study populations with a
substantial proportion of persons who have low or deficient
intakes of vitamin C (12,13). However, most studies con-
ducted with well-nourished populations have not demon-
strated an inverse association (14–17). To date, data from
primary prevention trials of supplementation are not avail-
able. The lack of clear evidence for a protective association
despite a plausible mechanism indicates the need to evaluate
further the association between vitamin C intake and risk of
CHD. We therefore examined the relation between dietary
and supplemental intake of vitamin C and risk of CHD in
a cohort of U.S. women during 16 years of follow-up.
METHODS
Study population. The Nurses’ Health Study was initiated
in 1976 when 121,700 female registered nurses 30 to 55
years of age and residing in 11 large U.S. states completed
a mailed questionnaire on their medical history and lifestyle
(18). Follow-up questionnaires have been sent every two
years thereafter to ascertain information on potential risk
factors and identify newly diagnosed cases of CHD and
other diseases. A semiquantitative food-frequency question-
naire (SFFQ) was developed to assess intake of micronutri-
ents and other components of diet.
A total of 98,482 women returned the diet questionnaire
in 1980. A priori, we excluded respondents who had
implausibly high (3,500 kcal/day) or low (500 kcal/day)
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total energy intake or those who left 10 or more items blank.
We further excluded women with cancer, except non-
melanoma skin cancer (n  3,499), or cardiovascular dis-
eases (i.e., angina, myocardial infarction [MI], stroke, or
other cardiovascular diseases, n  1,851) diagnosed before
1980 because these diagnoses may have led to a recent
change in diet. The final baseline sample consisted of
85,118 women who were followed up for 16 years for the
occurrence of CHD. More than 90% responded to the
subsequent biennial questionnaires, and about 80% com-
pleted the diet questionnaires at each follow-up assessment.
The Nurses’ Health Study was approved by the Institutional
Review Board of the Brigham and Women’s Hospital.
Ascertainment of diet and other exposures. Dietary in-
take of vitamin C and other aspects of diet were measured
using the SFFQs administered in 1980, 1984, 1986, 1990,
and 1994. For each food, a commonly used unit or portion
size (e.g., one egg or one slice of bread) was specified, and
the participant was asked how often, on average, during the
previous year she had consumed that amount. Nine re-
sponses were possible, ranging from “never or 1 per
month” to “6 times per day.” The intake of specific
nutrients was computed by multiplying the frequency of
consumption of each unit of food by the nutrient content of
the specified portion. Food composition values were ob-
tained from the Harvard University Food Composition
Database derived from U.S. Department of Agriculture
sources (19) and supplemented with manufacturer informa-
tion and other published values. We calculated the cumu-
lative average intake of each nutrient from all dietary
questionnaires available up to the start of every two-year
follow-up interval as described elsewhere (20). When di-
etary data were missing at the start of a new interval, we
carried forward the last available dietary data. The measure-
ment of glycemic load in the Nurses’ Health study was
reported elsewhere (21). We also ascertained brand of
breakfast cold cereal to take into account fortification with
vitamins. A detailed description of the dietary question-
naires and documentation of their reproducibility and va-
lidity have been published elsewhere (22–24).
The biennial, mailed questionnaire collected information
on several demographic, behavioral, and clinical variables
proven or suspected to be associated with CHD. During
each cycle, we asked participants to provide information on
use of multiple vitamins, specific brand, and usual number
of tablets taken per week. Information was also collected on
the use of specific supplements, including vitamin C,
vitamin E, and beta-carotene (only in 1984 and thereafter),
together with the dose of tablets and usual number of tablets
taken per week. We calculated total nutrient intake of
vitamin C, vitamin E, and beta-carotene as the sum of both
dietary and supplemental sources. The number of years of
past vitamin C supplement use was ascertained in 1980 and
updated every two years thereafter.
Ascertainment of end point. The primary end point for
this analysis was incident CHD, which included any non-
fatal MI or fatal coronary event diagnosed after the return of
the 1980 questionnaire but before June 1, 1996. For all
women who reported a diagnosis of CHD on a biennial
follow-up questionnaire, we requested permission to exam-
ine the medical records. An MI was considered confirmed if
it met the World Health Organization criteria of symptoms
and either typical electrocardiographic changes or elevated
cardiac enzymes (25). Infarctions of indeterminate age were
excluded. Infarctions that required hospital admission and
for which confirmatory information was obtained by inter-
view or letter, but for which no medical records were
available, were designated as probable. We included all
confirmed and probable cases in the analyses because results
were not substantially different after excluding probable
cases (data not shown).
Deaths were identified from state vital records and the
National Death index or reported by the women’s next of
kin and the postal system (26). Fatal CHD was confirmed
by hospital records or autopsy, or if CHD was listed as the
cause of death on the death certificate and evidence of
previous CHD was available. We designated as presumed
fatal CHD those cases in which CHD was the underlying
cause on the death certificate but for which no records were
available. These cases constituted about 24% of fatal CHD
cases. We also included sudden death within 1 h of onset of
symptoms in women with no other plausible cause (other
than coronary disease), which constituted 16% of fatal
CHD cases. Analyses limited to confirmed cases yielded
similar, although less precise results (data not shown).
Statistical methods. Person-time for each participant was
calculated from the date of return of the 1980 diet ques-
tionnaire to the date of the first CHD event, death, or June
1, 1996. Nutrients were energy-adjusted using the residual
method (27). For dietary exposures, women were catego-
rized into five equal groups according to quintiles of an
energy-adjusted nutrient. We used the cumulative average
of repeated measures of diet to reduce the within-person
variation in diet and more precisely represent long-term
intakes (20). Incidence rates were calculated by dividing the
number of events by the person-time of follow-up in each
quintile. The relative risk (RR) of a coronary event was
computed as the incidence rate in a specific category of
energy-adjusted intake of vitamin C divided by the rate in
the lowest category of intake, with adjustment for five-year
age categories. For the analyses of use of vitamin C
supplements, we compared the incidence rate in the cate-
gory of current users of supplements to that of non-users.
Abbreviations and Acronyms
CHD  coronary heart disease
CI  confidence interval
MI  myocardial infarction
RR  relative risk
SFFQ  semiquantitative food-frequency questionnaire
247JACC Vol. 42, No. 2, 2003 Osganian et al.
July 16, 2003:246–52 Vitamin C and CHD
We used pooled logistic regression (28) with two-year
follow-up periods, which is asymptotically equivalent to the
Cox-proportional-hazard regression, to model the incidence
of CHD in relation to the cumulative average of vitamin C
intake and adjust simultaneously for potentially confound-
ing variables shown in Table 1. Most non-dietary covariates
were ascertained and updated every two years. Indicator
variables were included for missing data on covariates. All
models also included an indicator variable for each two-year
time period during the study (8 periods). Tests of linear
trend across increasing quintiles of vitamin C intake were
conducted by assigning the medians of intake to categories
that were treated as a continuous variable in the regression.
All p values are two-sided.
To avoid a spurious finding due to the potential influence
of disease or prodromal illness on women’s diet, women
with prior diagnoses of other cardiovascular diseases or
cancer (except non-melanoma cancer) were excluded at
baseline, and women with new diagnoses were also censored
at the time of diagnosis during follow-up. Stratified analyses
were conducted to examine potential interactions between
use of vitamin C supplements and use of vitamin E
supplements, alcohol intake, smoking status, and diagnosis
of diabetes.
RESULTS
During 16 years of follow-up (1,240,566 person-years) from
1980 to 1994, we identified 1,356 incident cases of CHD:
973 nonfatal MIs (813 confirmed nonfatal cases) and 383
deaths from coronary disease (209 confirmed CHD deaths).
At baseline, mean energy-adjusted intake of vitamin C from
both supplements and diet was 304 mg/day with substan-
tially lower intakes from dietary sources alone (mean intake
 130 mg/day). Only 12% of women reported intakes
below 75 mg/day, the current recommended daily allowance
for non-smoking women, and approximately 19% of partic-
ipants took vitamin C supplements. The distributions of
energy-adjusted vitamin C intake from dietary sources only
were similar for users and non-users of vitamin C supple-
ments: median intake  128 mg/day and 118 mg/day,
respectively.
As shown in Table 1, median intake of vitamin C ranged
from 70 mg/day in the lowest quintile to 704 mg/day in the
highest quintile of intake. Participants with higher intakes
of vitamin C were less likely to smoke cigarettes and more
likely to exercise and take aspirin and supplements—
including multivitamins, vitamin E, and vitamin C—than
those with lower intakes. The majority of participants who
took vitamin C supplements were in the highest quintile of
Table 1. Characteristics of the Cohort According to Quintiles of Total Vitamin C Intake at Baseline (1980)
Quintile of Total Vitamin C Intake (mg)
1
(<93 mg/day)
2
(94–132 mg/day)
3
(133–183 mg/day)
4
(184–359 mg/day)
5
(>360 mg/day)
Characteristic
Median age (yrs) 45.0 45.0 46.0 46.5 48.0
Median body mass index (kg/m2) 23.2 24.4 24.5 24.4 24.1
High blood cholesterol* (%) 4.0 4.4 5.0 5.5 6.6
High blood pressure* (%) 12.4 14.1 16.4 17.9 16.6
Diabetes* (%) 1.4 2.1 2.2 2.5 2.2
Parental history of myocardial infarction
before age 60 yrs (%)
15.0 14.4 14.6 14.0 13.7
Current smoker (%) 37.2 28.4 26.1 24.4 26.2
7 aspirin/week (%) 12.6 13.2 13.9 14.1 18.5
Multivitamin users (%) 4.1 12.5 28.9 52.3 73.2
Vitamin C supplement users (%) 0.1 0.6 1.7 13.2 81.1
Vitamin E supplement users (%) 2.3 3.0 4.9 10.5 44.8
Exercise 2 h/week (%) 69.3 74.5 76.7 77.8 77.6
Current postmenopausal hormone use (%) 5.1 5.6 6.5 6.9 9.2
Median total caloric intake (kcal) 1,457 1,518 1,536 1,539 1,495
Median alcohol intake (gm) 1.8 1.8 1.8 1.7 1.8
Median nutrient intakes†
Saturated fat (g) 31.0 29.0 27.0 26.0 27.0
Polyunsaturated fat (g) 9.7 9.3 8.9 8.4 8.7
Transunsaturated fat (g) 4.4 4.1 3.8 3.5 3.5
Vitamin B6 (mg) 1.3 1.5 1.8 2.6 3.7
Folate (mcg) 172 237 306 418 452
Cereal fiber (g) 2.1 2.2 2.2 2.1 2.1
Glycemic load‡ 108 117 122 130 120
Total carotene (IU) 4,416 6,067 7,518 8,469 7,794
Vitamin E (IU) 5.1 5.8 6.9 14.9 41.3
Vitamin C (mg) 70 113 155 228 704
*Self-reported diagnosis of this condition. †Energy adjusted total nutrient intakes from 1980 semiquantitative food-frequency questionnaire. ‡Glycemic load was defined as an
indicator of blood glucose induced by an individual’s total carbohydrate intake. Each unit of glycemic load represents the equivalent of 1 g carbohydrate from white bread.
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total vitamin C intake. Those with higher total intakes of
vitamin C also consumed more folate, vitamin B6, total
carotene, and vitamin E—and somewhat less saturated fat.
Table 2 shows the RRs for CHD according to quintiles of
vitamin C intake. In multivariate models, adjusting for a
variety of other coronary risk factors and other dietary
antioxidants, only women in the highest relative to the
lowest quintile of intake were at moderately lower risk for
CHD (RR  0.73; 95% confidence interval [CI] 0.57 to
0.94). After excluding women who took vitamin C supple-
ments or multivitamins, there was no significant association
between vitamin C intake derived from diet only and risk of
CHD (RR  0.86; 95% CI 0.59 to 1.26 for the highest
relative to lowest quintile of intake from diet only). We
similarly found no association between intake of vitamin C
from diet only and risk of CHD among the subgroup of
vitamin C supplement users (multivariate RR  0.94; 95%
CI 0.56 to 1.60 for the highest relative to lowest quintile of
intake from diet only).
We then examined the association between CHD and
current vitamin C supplement use—including dose and
duration of use—among all participants. In general, women
who took vitamin C supplements differed somewhat from
those who did not (Table 3). Women who took vitamin C
supplements tended to have substantially higher intakes of
vitamin E, total carotene, folate, and vitamin B6. Vitamin C
supplement users included a higher proportion of those who
took vitamin E supplements and multivitamins. Women
who took supplements were also somewhat older, more
physically active, and less likely to smoke. In multivariate
models adjusting for a variety of coronary risk factors and
other dietary antioxidants, there was a significant 28% lower
risk of CHD among users than non-users of supplements
(RR  0.72; 95% CI 0.61 to 0.86) (Table 4). The RR was
essentially unchanged in multivariate models adjusting for
vitamin E supplement use of 100 IU/day or more and two
or more years duration (data not shown). Furthermore, we
found that use of vitamin C supplements for less than two
years was associated with no reduction in risk of CHD, but
the CIs were broad because of the small number of users in
this category. Use of vitamin C supplements for two to four
years was associated with an approximately 23% lower risk,
Table 2. Adjusted Relative Risks and 95% Confidence Intervals for Coronary Heart Disease (Nonfatal MI and Fatal CHD)
According to Quintile of Vitamin C Intake*
Variable
Quintile of Vitamin C Intake
p Value
Trend1 2 3 4 5
Total vitamin C intake (including
supplements)
Median intake (mg/day) 70 113 155 228 704
Range 93 94–132 133–183 184–359 360
No. of cases of CHD 296 261 281 302 216
Relative risk
Age adjusted 1.0 0.76 0.75 0.75 0.53 0.0001
95% CI — 0.64–0.90 0.64–0.90 0.64–0.89 0.44–0.63
Age- and smoking-adjusted 1.0 0.89 0.93 0.93 0.63 0.0001
95% CI — 0.75–1.05 0.78–1.09 0.79–1.10 0.53–0.76
Multivariate† 1.0 0.87 0.93 0.95 0.70 0.0008
95% CI — 0.72–1.05 0.75–1.15 0.77–1.17 0.55–0.88
Multivariate† plus total
Vitamin E and carotene intake 1.0 0.87 0.94 0.98 0.73 0.005
95% CI — 0.73–1.05 0.77–1.15 0.79–1.22 0.57–0.94
Dietary vitamin C intake (without
multivitamins or vitamin C
supplements)‡
Median intake (mg/day) 61 94 121 152 209
Range 79 80–108 108–135 135–173 174
No. of cases 119 106 106 109 118
Relative risk
Age-adjusted 1.0 0.79 0.74 0.69 0.73 0.03
95% CI — 0.61–1.03 0.57–0.96 0.53–0.89 0.57–0.95
Age- and smoking-adjusted 1.0 0.94 0.95 0.94 1.03 0.79
95% CI — 0.72–1.22 0.73–1.24 0.72–1.22 0.79–1.33
Multivariate† 1.0 0.90 0.85 0.83 0.85 0.46
95% CI — 0.67–1.20 0.62–1.16 0.59–1.16 0.58–1.24
Multivariate† plus total
Vitamin E and carotene intake 1.0 0.91 0.86 0.84 0.86 0.52
95% CI — 0.68–1.22 0.62–1.18 0.60–1.18 0.59–1.26
*Cumulative average intake of energy-adjusted nutrients. †Multivariate model adjusted for age, smoking, postmenopausal hormone use, parental history of myocardial infarction,
history of high blood pressure, history of high cholesterol, diabetes, body mass index, regular exercise, aspirin use, alcohol intake, total caloric intake, saturated fat intake,
polyunsaturated fat intake, transunsaturated fat intake, cereal fiber intake, folate intake, dietary glycemic load, and vitamin B6 intake. ‡Excludes women who take multivitamins
or vitamin C supplements.
CHD  coronary heart disease; CI  confidence interval; MI  myocardial infarction.
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and there was no consistent trend toward greater decrease in
risk with longer duration of use. In addition, we found no
significant differences in the RRs of CHD according to dose
of vitamin C supplements; however, the reduction in risk
was somewhat stronger among women who took at least
400 mg/day (Table 4).
Some investigators have suggested that antioxidants may
be more important among subgroups with higher oxidative
stress, such as cigarette smokers, those with high intakes of
alcohol, and those with diabetes. We found that the inverse
association between vitamin C supplement use and risk of
CHD was somewhat stronger among never-smokers (RR
0.54; 95% CI 0.39 to 0.77) and current smokers (RR 
0.72; 95% CI 0.55 to 0.94) than among former smokers
(RR  0.92; 95% CI 0.68 to 1.24); however, the variation
in risk among subgroups of smokers was not statistically
significant. Similarly, we found no statistically significant
variation in risk of CHD among subgroups with different
amounts of alcohol intake, including non-drinkers (RR 
0.74; 95% CI 0.56 to 0.96), women drinking 1 to 9 g/day
(RR  0.77; 95% CI 0.58 to 1.02), and women drinking
10 g/day (RR  0.85; 95% CI 0.56 to 1.30). The inverse
association between vitamin C supplement use and risk of
CHD was somewhat stronger among women with diabetes
(RR  0.57; 95% CI 0.37 0.88) compared with women
without diabetes (RR  0.76; 95% CI 0.63 to 0.91),
although the RRs were not significantly different. Vitamin
C may play an important role in regenerating vitamin E by
reducing the tocopheroxyl radical back to the active tocoph-
erol form (29); therefore, antioxidants may act synergisti-
cally. However, we found similarly lower risks of CHD
among vitamin C supplement users who also took vitamin E
supplements (RR  0.80; 95% CI 0.53 to 1.23) or did not
(RR  0.70; 95% CI 0.56 to 0.88).
DISCUSSION
In this large prospective study of women, we observed a
modest inverse association between intake of vitamin C and
incidence of CHD. Women in the highest quintile of
vitamin C intake (360 mg/day) from diet and supple-
ments had a 27% lower risk of nonfatal MI and fatal CHD
than women in the lowest quintile of intake (93 mg/day).
The reduction in risk appeared to be limited to women who
took vitamin C supplements. Among users of vitamin C
supplements, we observed a significant 28% lower risk of
nonfatal MI and fatal CHD than among non-users. Al-
Table 3. Characteristics of the Cohort According to Vitamin C
Supplement Use at Baseline (1980)*
Non-User of
Vitamin C
Supplements
(n  68,666)
User of
Vitamin C
Supplements
(n  16,186)
Characteristic
Median age (yrs) 46 48
Median body mass index (kg/m2) 24.4 24.0
High blood cholesterol† (%) 4.8 6.4
High blood pressure† (%) 15.4 15.8
Diabetes† (%) 2.0 2.1
Parental history of myocardial infarction
before age 60 yrs (%)
14.6 13.2
Current smoker (%) 29.3 25.3
Exercise 2 h/week (%) 74.4 77.9
7 aspirin/week (%) 13.7 17.8
Current postmenopausal hormone use (%) 6.2 8.6
Vitamin E supplement users (%) 4.2 50.1
Multivitamin users (%) 26.0 67.2
Median alcohol intake (g/day) 1.8 1.8
Median total caloric intake (kcal/day) 1,506 1,522
Median nutrient intakes (U/day)‡
Saturated fat (g) 28.0 27.0
Polyunsaturated fat (g) 9.0 8.9
Transunsaturated fat (g) 4.0 3.6
Folate (mcg) 259 450
Vitamin B6 (mg) 1.6 3.2
Cereal fiber (gm) 2.2 2.2
Glycemic load§ 120 118
Total carotene (IU) 6,408 7,475
Vitamin E (IU) 6.3 52.3
Vitamin C (mg) 132 672
*Excludes 266 participants with missing data on vitamin C supplement use.
†Self-reported diagnosis of this condition. ‡Energy-adjusted total nutrient intakes
from 1980 semiquantitative food-frequency questionnaire. §Glycemic load was
defined as an indicator of blood glucose induced by an individual’s total carbohydrate
intake. Each unit of glycemic load represents the equivalent of 1 g carbohydrate from
white bread.
Table 4. Adjusted Relative Risks and 95% Confidence Intervals
for Coronary Heart Disease (Nonfatal MI and Fatal CHD)*
According to Use of Vitamin C Supplements†
Vitamin C Supplement Users
No. of Cases
Among Users
Relative Risk
(95% CI)
Among vitamin C supplement users
Age-adjusted 227 0.62 (0.54–0.73)
Age- and smoking-adjusted 0.65 (0.56–0.76)
Multivariate‡ 0.71 (0.61–0.84)
Multivariate‡ plus total vitamin E
and carotene intake
0.72 (0.61–0.86)
Among vitamin C supplement users,
doses of§
1–400 mg/day 45 0.82 (0.60–1.12)
401–749 mg/day 89 0.69 (0.55–0.87)
750 mg/day or more 79 0.71 (0.55–0.92)
Among vitamin C supplement users,
durations of§
2 yrs 5 1.12 (0.46–2.77)
2–4 yrs 114 0.77 (0.63–0.94)
5–9 yrs 53 0.84 (0.63–1.13)
10 or more yrs 54 0.70 (0.51–0.94)
*Self-reported diagnosis of this condition. †Analysis includes 729 cases of CHD
among non-users of supplements and 956,579 total person years of follow-up.
‡Multivariate model adjusted for age, smoking, body mass index, postmenopausal
hormone use, parental history of MI, history of high blood pressure, history of high
cholesterol, diabetes, physical activity, aspirin use, alcohol intake, total caloric intake,
glycemic load, saturated fat intake, transunsaturated fat intake, polyunsaturated fat
intake, cereal fiber intake, folic acid intake, and vitamin B6 intake. Analysis excludes
14 cases missing dose information. §Multivariate model adjusted for age, smoking,
body mass index, postmenopausal hormone use, parental history of MI, history of
high blood pressure, history of high cholesterol, diabetes, physical activity, aspirin use,
alcohol intake, total caloric intake, glycemic load, saturated fat intake, transunsat-
urated fat intake, polyunsaturated fat intake, cereal fiber intake, folic acid intake,
vitamin B6 intake, vitamin E intake, and carotene intake. Analysis excludes 1 case
missing duration-of-use information.
Abbreviations as in Table 2.
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though risk did not vary significantly according duration of
use of supplements or dose of supplements, the reduction in
risk was somewhat stronger for women taking at least 400
mg/day.
The lack of a relation between the risk of CHD and the
dose and duration of use of vitamin C supplements is
compatible with data on its bioavailability. Intestinal ab-
sorption of vitamin C is an active, saturable, and dose-
dependent process (30). Pharmacokinetic data indicate that
for doses as low as 100 to 200 mg/day, the amount is
completely absorbed and tissues are saturated (31–33). In a
sample of healthy women undergoing vitamin C repletion,
steady-state plasma concentrations measured after the ad-
ministration of a range of oral doses of pure vitamin C
revealed a steep sigmoidal relationship that started to
plateau at approximately 100 mg/day (33). Plasma and
tissue saturation occurred between oral doses of 200 and 400
mg daily, and saturation was achieved within two months.
As suggested by Levine et al. (32), high doses of vitamin C
may, therefore, not impact body stores or disease risk.
Results from prospective investigations of the relation-
ship between plasma levels or dietary intakes of vitamin C
and the incidence of CHD have been mixed (11,31). An
apparent benefit has been observed in some populations
with relatively low or deficient intakes. The Kuopio Isch-
emic Heart Disease Study observed a significantly lower risk
(63%) of fatal and nonfatal MI (RR 0.37; 95% CI 0.18 to
0.77) among Finnish men whose baseline plasma vitamin C
levels were above 64.8 mol/l than among those whose
baseline plasma vitamin C levels were considered deficient
(11.4 mol/l) (12). The Prospective Basel Study found a
modest non-significant inverse relation with CHD mortal-
ity (RR  0.80; 95% CI 0.50 to 1.33) among persons with
relatively low plasma vitamin C levels (below vs. above 23
mol/l) (34); however, the RR may have been weakened by
comparing more broadly defined categories of plasma levels.
With respect to diet, the Finnish Mobile Clinic Study
found a significantly lower risk of death from CHD for
women in the highest (91 mg/day) relative to the lowest
(61 mg/day) tertile of intake (adjusted RR  0.49; 95%
CI 0.24 to 0.98) and no association in men (adjusted RR 
1.00; 95% CI 0.68 to 1.45), despite similar distributions of
vitamin C intake (35). Results from other cohorts with
similarly low intakes of vitamin C have shown either a
modest non-significant inverse association (36–38) or no
association (39).
Among cohorts similar to ours, with relatively higher
distributions of vitamin C intake and substantial numbers of
supplement users, data on the association between CHD
and vitamin C intake or supplement use have been incon-
sistent. Sahyoun et al. (16) observed a significantly lower
risk of death (62%) from CHD (RR  0.38; 95% CI 0.19
to 0.75) for those in the highest (388 mg/day) than for
those in the lowest (90 mg/day) quintile of total intake in
an elderly population. After excluding supplement users,
there was no association with mortality; however, vitamin C
supplement use was not independently associated with
CHD. The Health Professionals Follow-up Study (n 
39,910) found a non-significant increased risk of CHD (RR
 1.25; 95% CI 0.91 to 1.71) among men in the highest
(median intake 1,162 mg/day) compared with the lowest
(median intake 92 mg/day) quintile of intake (14). Vitamin
C supplement users were at moderately lower risk, although
the association was not statistically significant. Kushi et al.
(15) found a non-significant increased risk of death from
CHD (RR  1.49; 95% CI 0.96 to 2.30) for women in the
highest (391 mg/day) compared with the lowest quintile
(113 mg/day) of total vitamin C intake and no association
with vitamin C supplement use. Similarly, Losconszy et al.
(17) found no association between vitamin C supplement
use and mortality from CHD in an elderly cohort of men
and women. The First National Health and Nutrition
Examination Study (NHANES I) Epidemiologic
Follow-up Study (40) found a 25% lower risk of mortality
from all cardiovascular disease (RR  0.75; 95% CI 0.55 to
0.99) only among women who consumed 50 mg/day or
more of vitamin C and took supplements.
The strengths of our study include its prospective design
and high rates of follow-up. The prospective collection of
information eliminates the possibility of biased recall of diet.
High rates of cohort participation lessen the potential for
differential losses to follow-up that threaten internal valid-
ity. Weaknesses include the use of dietary questionnaires to
assess the dietary vitamin C intake that moderately corre-
lates with plasma levels, and the fact that the population we
examined was well nourished and had a relatively narrow
range of intakes, especially among non-users of vitamin C
supplements. Furthermore, our findings do not provide
information about the possible benefits of vitamin C intake
in patients with risk factors or known cardiovascular disease.
In the present study, adjustment for several of the recog-
nized physiologic and lifestyle risk factors for CHD atten-
uated the estimates of RR, demonstrating at least moderate
confounding by the risk factors measured in our study.
Nevertheless, we cannot exclude the possibility of residual
confounding by an imprecisely measured risk factor or an
unmeasured risk factor that is highly associated with vitamin
C supplement use and a strong risk factor for CHD.
In conclusion, our findings suggest that vitamin C sup-
plement users may be at lower risk of CHD. We found no
evidence for a gradient in risk across the relatively narrow
range of intakes of vitamin C from diet in our study
population. Although we cannot exclude a physiologic
benefit of supplemental vitamin C, we also cannot exclude
the possibility that the association may be attributed to some
unmeasured health-seeking characteristic among vitamin C
supplement users. The inconsistent findings from available
observational studies emphasize the need for further evi-
dence from prospective studies and randomized clinical
trials before public policy recommendations regarding the
optimal intake of vitamin C or the need for supplements.
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